Nikolaos Dagres
A5068179532- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiovascular Syncope and Autonomic Disorders
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Ischemia and Reperfusion
- Acute Myocardial Infarction Research
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- ECG Monitoring and Analysis
- Cardiovascular Disease and Adiposity
- Coronary Interventions and Diagnostics
- Cardiac Valve Diseases and Treatments
- Heart Rate Variability and Autonomic Control
- Blood Pressure and Hypertension Studies
- Anesthesia and Neurotoxicity Research
- Viral Infections and Immunology Research
Charité - Universitätsmedizin Berlin
2011-2025
Leipzig Heart Institute
2015-2024
Deutsches Herzzentrum der Charité
2015-2024
Humboldt-Universität zu Berlin
2024
Freie Universität Berlin
2024
German Center for Lung Research
2024
German Society of Medical Intensive Care and Emergency Medicine
2024
Vivantes Klinikum
2024
Max Delbrück Center
2024
European Society of Cardiology
2017-2024
Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Vedran Velagic (Croatia), Sami Viskin (Israel)
CV Cardiovascular CYP Cytochrome P (CYP) Unfractionated heparin ULN Upper limit of normal VENTURE-AF Active-controlled multi-center study with blind-adjudication designed to evaluate the safety uninterrupted Rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for non-valvular Atrial Fibrillation VHD Valvular heart disease VKA Vitamin antagonist VTE Venous thromboembolic event WOEST What is Optimal antiplatelet anticoagulant therapy patients oral anticoagulation...
The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE).Prospective cohort 3116 adult (2470 from Europe, 646 non-ESC countries), admitted 156 hospitals in 40 countries between January 2016 March 2018 a diagnosis IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed (18F-FDG PET/CT)] data were...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
ESC.
Pacemakers, implantable cardiac defibrillators, and resynchronization therapy devices are potentially life-saving treatments for a number of conditions, but not without risk. Most concerning is the risk electronic device (CIED) infection, which associated with significant morbidity, increased hospitalizations, reduced survival, healthcare costs. Recommended preventive strategies such as administration intravenous antibiotics before implantation well recognized. Uncertainties have remained...
Catheter ablation is potentially curative treatment for atrial fibrillation (AF). However, complications are more frequent and severe compared with other procedures. We investigated the complication rate in 1,000 AF procedures a high-volume center examined possible risk factors.One thousand consecutive circumferential pulmonary vein radiofrequency ablations were performed symptomatic, drug-refractory AF. Major defined as ones that life threatening, caused permanent harm, required...
The population of patients with congenital heart disease (CHD) is continuously increasing more and reaching adulthood. A significant portion these young adults will suffer from arrhythmias due to the underlying defect itself or as a sequela interventional surgical treatment. medical community encounter an challenge even most individuals complex defects nowadays become adults. Within past 20 years, management has gained remarkable progress including pharmacological treatment, catheter...
Abstract Pacemakers, implantable cardiac defibrillators, and resynchronization therapy devices are potentially life-saving treatments for a number of conditions, but not without risk. Most concerning is the risk electronic device (CIED) infection, which associated with significant morbidity, increased hospitalizations, reduced survival, healthcare costs. Recommended preventive strategies such as administration intravenous antibiotics before implantation well recognized. Uncertainties have...
The ESC-EHRA Atrial Fibrillation Ablation Long-Term registry is a prospective, multinational study that aims at providing an accurate picture of contemporary real-world ablation for atrial fibrillation (AFib) and its outcome.A total 104 centres in 27 European countries participated were asked to enrol 20-50 consecutive patients scheduled first re-do AFib ablation. Pre-procedural, procedural 1-year follow-up data captured on web-based electronic case record form. Overall, 3630 included, which...
The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. Download a PDF the Research Summary. We conducted single-center, open-label trial Germany that involved who were referred for transplantation evaluation. Patients assigned to receive guideline-directed medical therapy or alone. primary end point was composite death from any cause, implantation left ventricular assist device, urgent transplantation. A total 97 group...
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with European Association Cardio-Thoracic Surgery (EACTS)
Abstract With the global increase in device implantations, there is a growing need to train physicians implant pacemakers and implantable cardioverter-defibrillators. Although are international recommendations for indications programming, no consensus date regarding implantation technique. This document founded on systematic literature search review, from an task force. It aims fill gap by setting standards implantation.
Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity mortality even on optimal current therapy. This document summarizes key outcomes 8th AFNET/EHRA Consensus Conference Atrial Fibrillation NETwork (AFNET) European Heart Rhythm Association (EHRA). Eighty-three international experts met Hamburg for 2 days October 2021. Results interdisciplinary, hybrid discussions breakout groups plenary...
Abstract In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing most common cardiac arrhythmia. 2007, first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence technological advances have resulted a rapidly changing landscape field ablation, thus stressing need regularly updated versions this partnership which were...
Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. contributes to progression symptoms and signs HF confers worse prognosis. The management patients SMR is complex requires timely referral a multidisciplinary Heart Team. Optimization pharmacological device therapy according guideline recommendations crucial....
Abstract There is an increasing proportion of the general population surviving to old age with significant chronic disease, multi-morbidity, and disability. The prevalence pre-frail state frailty syndrome increases exponentially advancing associated greater morbidity, disability, hospitalization, institutionalization, mortality, health care resource use. Frailty represents a global problem, making early identification, evaluation, treatment prevent cascade events leading from functional...